On the horizon: Immunotherapy strategies for relapsed/refractory high-risk neuroblastoma (1.50 AMA credits)

On the horizon: Immunotherapy strategies for relapsed/refractory high-risk neuroblastoma (1.50 AMA credits)
October 12, 2020 ology
Current Status
Not Enrolled
Price
Free
Get Started

Physician continuing medical education (AMA)
The Postgraduate Institute for Medicine designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.